In this section
2021 Pediatric Cancer Symposium
Exploring Immunotherapy in Pediatric Cancers
Presented by Northwestern Mutual Foundation
Day 1: Tuesday, May 11 (4-7 PM CST)
Neuroblastoma (View recorded session)
4 - 4:15 p.m. | Welcome and Overview of Topic by Cindy Schwartz, MD, MPH
4:15 – 5 p.m. | Immunotherapy for Neuroblastoma: Past, Present and Future by Ken DeSantes, MD
5 - 5:45 p.m | . Bringing Novel Agents to the Neuroblastoma Clinic by Steve DuBois, MD, MS
5:45 - 6:30 p.m. | Neuroblastoma Tumor Microenvironment: identifying biomarkers of resistance and response to immunotherapy by Shahab Asgharzadeh, MD
6:30 – 7 p.m. | Live Q&A and Closing Remarks by Mike Burke, MD
Day 2: Wednesday, May 12 (4-7 PM CST)
CAR-T Therapy (View recorded session)
4 - 4:15 p.m. | Welcome by Sid Rao, MD
4:15 – 5 p.m. | CAR T-Cells in Pediatric Leukemia: Going Beyond CD19 by Nirali Shah, MD MHSc
5 - 5:45 p.m. | Final Results of a Phase 1 LV20.19 CAR Trial and Future Directions by Nirav Shah, MD MSHP
5:45 - 6:30 p.m. | Approaches to Relapsed B-ALL in Children in the Age of Immune and Cell Therapy: Optimizing Cure and Decreasing Toxicity by Mike Pulsipher, MD
6:30 – 7 p.m. | Live Q&A, Abstract Winner Announcement and Closing Remarks